About QuantuMDx
QuantuMDx is a company based in Newcastle Upon Tyne (United Kingdom) founded in 2008. QuantuMDx has raised $57.26 million across 6 funding rounds from investors including Gov.uk, British Business Bank and Adjuvo. QuantuMDx has completed 1 acquisition, including NorthGene. QuantuMDx offers products and services including Q-POC Platform, CAPTURE-XT, Respiratory Solution, and TB Host Immune Response Assay. QuantuMDx operates in a competitive market with competitors including Nanopore, PacBio, Omniome, Complete Genomics and OpGen, among others.
- Headquarter Newcastle Upon Tyne, United Kingdom
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Quantumdx Group Limited
- Date of Incorporation 04 Mar, 2008
- Jurisdiction NEWCASTLE UPON TYNE, ENGLAND
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of QuantuMDx
QuantuMDx offers a comprehensive portfolio of products and services, including Q-POC Platform, CAPTURE-XT, Respiratory Solution, and TB Host Immune Response Assay.
Rapid multiplex PCR system for point-of-care diagnostics.
Platform for capturing and processing diagnostic samples.
Assay for detecting respiratory infections like SARS-CoV-2.
Test for tuberculosis immune response detection.
People of QuantuMDx
Unlock access to complete
Unlock access to complete
Funding Insights of QuantuMDx
QuantuMDx has successfully raised a total of $57.26M across 6 strategic funding rounds. The most recent funding activity was a Series D round of $19.18 million completed in August 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in QuantuMDx
QuantuMDx has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Gov.uk, British Business Bank and Adjuvo.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
London-based startups in CleanTech, Manufacturing, and Media sectors are funded.
|
Locked | Locked | Locked | |
|
Private debt fund and fund of funds focused on startups
|
Locked | Locked | Locked | |
|
Early-stage healthcare investments are made by 3B Future Health Fund.
|
Locked | Locked | Locked |
Investor details for QuantuMDx
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by QuantuMDx
QuantuMDx has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include NorthGene.
Investment portfolio details for QuantuMDx
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
DNA testing for legal, personal, and forensic purposes is provided.
|
Locked | Locked | 1994 | Locked |
Complete acquisition details for QuantuMDx
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - QuantuMDx
Detailed financials for QuantuMDx
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Quantumdx Comparisons
Peer comparison for QuantuMDx
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of QuantuMDx
QuantuMDx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nanopore, PacBio, Omniome, Complete Genomics and OpGen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Nanopore-based electronic systems for single-molecule analysis are developed.
|
|
| Locked | Locked | Locked |
Instrument systems and software for single-molecule real-time sequencing are developed.
|
|
| Locked | Locked | Locked |
Genome sequencing platform is provided for clinical diagnostics.
|
|
| Locked | Locked | Locked |
DNA sequencing platform for human genome analysis is developed.
|
|
| Locked | Locked | Locked |
Developer of diagnostics and bioinformatics platforms for providers
|
|
| Locked | Locked | Locked |
Provider of DNA sequencing technologies for applied genomic testing and medical sequencing
|
Detailed competitors of QuantuMDx
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Quantumdx
Complete news archive for QuantuMDx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about QuantuMDx
QuantuMDx was founded in 2008 and raised its 1st funding round 5 years after it was founded.
QuantuMDx is headquartered in Newcastle Upon Tyne, United Kingdom.
QuantuMDx is a funded company, having raised a total of $57.26M across 6 funding rounds to date.
QuantuMDx was founded in 2008 and is based in Newcastle Upon Tyne, United Kingdom. Operations focus on the diagnostics sector, where handheld and portable low-cost platforms for DNA analysis and virus detection are developed. The Q-POC device supports sequencing and diagnostic applications. Personalized healthcare delivery is enabled through these technologies, with emphasis on accessibility in clinical settings.
QuantuMDx's top competitors include Nanopore, PacBio and Complete Genomics.
QuantuMDx offers Q-POC Platform, CAPTURE-XT, Respiratory Solution, and TB Host Immune Response Assay.
QuantuMDx has made 1 acquisition, including NorthGene.
QuantuMDx has 4 investors. Key investors include Gov.uk, British Business Bank, Adjuvo, and 3B Future Health Fund.